Health economic evaluation of bivalirudin in the management of patients undergoing percutaneous coronary intervention in Belgium

被引：0
|
作者：
Ethgen, O
Lamotte, M
Annemans, L
机构：
[1] Univ Liege, Liege, Belgium
[2] HEDM IMS Hlth, Brussels, Belgium
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67173-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [1] Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention
    Rehmani, Ahmed
    Judkins, Chris
    Lee, Edmund
    Nguyen, Michael
    Whelan, Alan
    Schultz, Carl
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [2] Bivalirudin confers antiplatelet effects in patients undergoing percutaneous coronary intervention
    Anand, SX
    Kim, MC
    Kamran, M
    Sharma, SK
    Carbon, F
    Cavusoglu, E
    Viles-Gonzalez, JF
    Badimon, JJ
    Marmur, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 37A - 37A
  • [3] Bivalirudin - A review of its use in patients undergoing percutaneous coronary intervention
    Moen, MD
    Keating, GM
    Wellington, K
    DRUGS, 2005, 65 (13) : 1869 - 1891
  • [4] SAFETY AND OUTCOMES OF BIVALIRUDIN IN DIALYSIS PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Delhaye, Cedric
    Maluenda, Gabriel
    Wakabayashi, Kohei
    Ben-Dor, Itsik
    Collins, Sara D.
    Syed, Asmir I.
    Gonzalez, Manuel A.
    Gaglia, Michael A.
    Torguson, Rebecca
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Lindsay, Joseph
    Pichard, Augusto D.
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [5] Safety and Effectiveness of Bivalirudin in Routine Care of Patients Undergoing Percutaneous Coronary Intervention
    Rassen, Jeremy A.
    Mittleman, Murray A.
    Glynn, Robert J.
    Brookhart, M. Alan
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S7 - S7
  • [6] Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
    Chen, Wenron
    Lu, Dang
    Huang, Zuoming
    Xiao, Lin
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 94 (06) : 898 - 899
  • [7] SAFETY OF HEPARIN COMPARED WITH BIVALIRUDIN IN PATIENTS UNDERGOING TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION
    Bittl, John A.
    Stables, Rod
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1346 - 1346
  • [8] The clinical and economic impact of bivalirudin for percutaneous coronary intervention
    Malik, Nikesh
    Gershlick, Anthony H.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (06) : 699 - 706
  • [9] Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention
    Mahmoudi, M.
    Waksman, R.
    MINERVA CARDIOANGIOLOGICA, 2012, 60 (01): : 95 - 100
  • [10] Bivalirudin decreases the antiplatelet effect of eptifibatide in patients undergoing percutaneous coronary intervention
    Saucedo, JF
    Aude, W
    Pacheco, R
    Thorn, B
    Matin, Z
    Garza, L
    CIRCULATION, 2003, 108 (17) : 578 - 578
12345